Research & Development
NBE-Therapeutics will leverage its in-house developed Transpo-mAb and SMAC-Technology for the development of potent next-generation ADC product candidates providing improved treatment options for cancer patients.
- San Diego, USA, 2019-03-04 - NBE-Therapeutics invited to present at Terrapinn's Americas Antibody Congress
- San Diego, USA, 2018-12-11 - NBE-Therapeutics was invited to present at KNect365's 2018 Antibody Engineering & Therapeutics Conference
- Basel, 2018-11-15 - Dr. Anthony Tolcher joins the Scientific Advisory Board of NBE-Therapeutics